PR-positive patients in endometrioid and high-grade ovarian serous carcinomas had a better prognosis, while there was no significant correlation between PR positive expression and prognosis in patients with low-grade ovarian serous, mucinous carcinomas and clear cell carcinomas [17]. The gene discussed is PGR; the disease is ovarian serous carcinoma.